Despite the fact that Singulair is a widely used antihistamine, lawsuits against Merck & Co. allege that the medication causes adverse mental health effects. If you have used Singulair and have experienced these symptoms, you may be eligible to receive compensation. According to the FDA, the new warnings are based on reports of neuropsychiatric incidents, animal studies, and cases of suicide. In the latest reports, the FDA cited 82 reports of suicidal behavior, 45 of which involved patients over the age of 17. The remaining 19 cases did not specify age.

More than nine million people have been prescribed the antihistamine Singulair. Of these, about 2.3 million of those prescriptions were given to children. In light of this warning, patients should discuss the potential risks and benefits of taking Singulair with their doctor. In addition, they should avoid taking the medication if they have a mental illness, because withdrawal symptoms can cause mood or behavior changes. For more information, contact a Singulair attorney at Mckay Law.

If you’ve suffered from Singulair side effects, you may be eligible to file a lawsuit against Merck & Co. or your doctor. The agency has provided data from a database of adverse drug events. However, many experts believe that this database represents a fraction of actual patient problems. Therefore, the number of reports that the FDA has received may be underestimated. As a result, Singulair side effects should be considered carefully before taking it. Click Here Singulair mental health symptoms

Singulair users report a variety of side effects, including depression and anxiety. It has even been associated with suicidal thoughts and even completed suicides. Despite the countless reported adverse reactions, the company continues to sell Singulair. And the company continues to sell it. As a result, the drug’s side effects remain unresolved. Singulair has prompted thousands of lawsuits.

The FDA provided data on the number of patients affected by Singulair. The database is part of the FDA’s Adverse Event Reporting System (FAERS) and is a repository for reports of adverse drug events. The database is incomplete and contains only a small fraction of the real-life problems associated with Singulair. But some experts believe that the thousands of reports represent only a small portion of the true number of cases.

Singulair is linked with a wide range of psychological and behavioral symptoms. Moreover, users report that Singulair withdrawal can last for weeks or even months. Considering the severity of the mental health problems associated with Singulair, it is important to note that the FDA’s data are based on observational studies and ongoing reports. These reports, however, do not constitute an exhaustive list of all Singulair adverse events.